In last trading session, NKGen Biotech Inc (NASDAQ:NKGN) saw 0.43 million shares changing hands with its beta currently measuring 0.59. Company’s recent per share price level of $0.64 trading at $0.07 or 13.25% at ring of the bell on the day assigns it a market valuation of $22.73M. That closing price of NKGN’s stock is at a discount of -534.37% from its 52-week high price of $4.06 and is indicating a premium of 68.75% from its 52-week low price of $0.20. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.33 million shares which gives us an average trading volume of 1.34 million if we extend that period to 3-months.

NKGen Biotech Inc (NASDAQ:NKGN) trade information

Upright in the green during last session for gaining 13.25%, in the last five days NKGN remained trading in the green while hitting it’s week-highest on Friday, 12/20/24 when the stock touched $0.64 price level, adding 1.54% to its value on the day. NKGen Biotech Inc’s shares saw a change of -76.73% in year-to-date performance and have moved 28.05% in past 5-day. NKGen Biotech Inc (NASDAQ:NKGN) showed a performance of 104.47% in past 30-days. Number of shares sold short was 0.87 million shares which calculate 0.9 days to cover the short interests.

NKGen Biotech Inc (NASDAQ:NKGN)’s Major holders

Insiders are in possession of 42.32% of company’s total shares while institution are holding 12.19 percent of that, with stock having share float percentage of 21.14%. Investors also watch the number of corporate investors in a company very closely, which is 12.19% institutions for NKGen Biotech Inc that are currently holding shares of the company.